Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report)'s stock price reached a new 52-week high on Thursday . The company traded as high as $9.09 and last traded at $8.93, with a volume of 73960 shares changing hands. The stock had previously closed at $8.95.
Wall Street Analyst Weigh In
AVAH has been the topic of several analyst reports. Barclays raised shares of Aveanna Healthcare from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Jefferies Financial Group raised Aveanna Healthcare from a "hold" rating to a "buy" rating and dropped their price objective for the stock from $6.25 to $6.00 in a report on Monday, July 21st. UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and raised their target price for the company from $6.75 to $8.00 in a report on Tuesday, August 19th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Aveanna Healthcare in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare presently has an average rating of "Hold" and a consensus price target of $7.92.
Check Out Our Latest Stock Report on AVAH
Aveanna Healthcare Price Performance
The business's 50-day moving average price is $7.55 and its two-hundred day moving average price is $5.81. The firm has a market cap of $1.84 billion, a price-to-earnings ratio of 110.13 and a beta of 2.05.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Summit Partners L P purchased a new stake in Aveanna Healthcare in the second quarter valued at approximately $50,477,000. Assenagon Asset Management S.A. acquired a new stake in shares of Aveanna Healthcare during the 3rd quarter worth $7,356,000. First Eagle Investment Management LLC boosted its holdings in Aveanna Healthcare by 12.1% in the second quarter. First Eagle Investment Management LLC now owns 810,667 shares of the company's stock valued at $4,240,000 after acquiring an additional 87,500 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Aveanna Healthcare by 103.9% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 664,890 shares of the company's stock valued at $3,477,000 after acquiring an additional 338,746 shares during the last quarter. Finally, Squarepoint Ops LLC grew its position in Aveanna Healthcare by 207.0% during the second quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock valued at $2,510,000 after acquiring an additional 323,656 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
